Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-58037

Mikhailidis, D P; Elisaf, M; Rizzo, M; Berneis, K; Griffin, B; Zambon, A; Athyros, V; de Graaf, J; März, W; Parhofer, K G; Rini, G B; Spinas, G A; Tomkin, G H; Tselepis, A D; Wierzbicki, A S; Winkler, K; Florentin, M; Liberopoulos, E (2011). "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Current Vascular Pharmacology, 9(5):533-571.

[img]Published Version
PDF - Registered users only
1MB

Abstract

Aim of the present Consensus Statement is to provide a comprehensive and up to-date document on the pathophysiology, atherogenicity and clinical significance of low density liproproteins (LDL) subclasses. We sub-divided our statement in 2 sections. section I discusses the pathophysiology, atherogenicity and measurement issues, while section II is focused on the effects of drug and lifestyle modifications. Suggestions for future research in the field are highlighted at the end of section II. Each section includes Conclusions.

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Endocrinology and Diabetology
DDC:610 Medicine & health
Language:English
Date:2011
Deposited On:03 Feb 2012 08:59
Last Modified:07 Feb 2014 04:12
Publisher:Bentham Science Publishers
ISSN:1570-1611 (P) 1875-6212 (E)
Official URL:http://www.ingentaconnect.com/content/ben/cvp/2011/00000009/00000005/art00002
Related URLs:http://benthamscience.com/cvp/ (Publisher)
PubMed ID:21595628
Citations:Web of Science®. Times Cited: 77
Google Scholar™
Scopus®. Citation Count: 55

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page